VideoHIVViral Hepatitis and Liver DiseaseAndrea De Luca Lecture: The Top 10 Important Observations of the Last Year Affecting Clinical Management - Dr. Jade GhosnView Video
VideoHIVViral Hepatitis and Liver DiseaseTransmitted and Acquired Resistance: Special Populations - Anca Streinu - Cercel, MD, PhDView Video
VideoHIVViral Hepatitis and Liver DiseaseFirst Day Treatment, Definition, and Review of Data Paul Sax, MDView Video
VideoHIVViral Hepatitis and Liver DiseaseImplementing First Day Treatment in Europe: Western Perspective Margaret Johnson, MD, FRCPView Video
VideoHIVViral Hepatitis and Liver DiseaseImplementing First Day Treatment in Europe: Central and Eastern Perspective Milosz Parczewski, MD, PhDView Video
VideoHIVViral Hepatitis and Liver DiseaseResistance to Long-Acting Antivirals - Anne-Geneviève Marcelin, PharmD, PhDView Video
VideoHIVViral Hepatitis and Liver DiseaseManagement of the COVID 19 Pandemic in Europe: Diagnostics - Ravindra Gupta, MD, PhDView Video
VideoHIVViral Hepatitis and Liver DiseaseManagement of the COVID 19 Pandemic in Europe - Physiopathology and treatment - Xavier Lescure, MD, PhDView Video
VideoHIVViral Hepatitis and Liver DiseaseTreatment of Hepatitis B for HIV Clinicians - Anna Maria Geretti, MD, PhDView Video
VideoHIVViral Hepatitis and Liver DiseaseHepatitis C Resistance: Con Standpoint - JM Pawlotsky, MD, PhDView Video
VideoHIVViral Hepatitis and Liver DiseaseHepatitis C Resistance: Pro Standpoint - Francesca Ceccherini - Silberstein, PhDView Video
VideoHIVViral Hepatitis and Liver DiseaseHCV Nextstrain - a phylogenetic tool to monitor HCV drug resistance and transmission - Anita Howe, PhDView Video
VideoHIVViral Hepatitis and Liver DiseaseOverview of the current situation regarding PrEP and resistance - Daniel Kuritzkes, MDView Video
VideoHIVViral Hepatitis and Liver DiseaseChallenges to Widespread PrEP in Europe: Clinical Aspects - Milosz Parczewski, MD, PhDView Video
VideoHIVViral Hepatitis and Liver DiseaseChallenges to Widespread PrEP in Europe: Social Aspects - Michael MeulbroekView Video
VideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting Session 1: Abstract Driven PresentationsView Video
VideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting Session 2: Abstract Driven PresentationsView Video
VideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting | Session 3: Abstract #9 - Kristen AndreattaView Video
VideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting | Session 4: Abstract #11 - Velia Chiara Di MaioView Video
VideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting | Covid-19 Sattelite: Abstract #33 - Mohammad AlkhatibView Video
VideoHIVViral Hepatitis and Liver DiseaseSatellite: Management of the COVID 19 Pandemic in Europe: Clinical relevance of diagnostic testing - Carlo PernoView Video
VideoHIVViral Hepatitis and Liver DiseasePatients with Poor or Good Adherence: Who Will Benefit More from Long Acting Therapy? - Charles Flexner, MDView Video